Tremor International - Director Dealings
("Tremor" or the "Company")
Director Dealings Pursuant to Previously Established Non-Discretionary Plans to Trade Under Rule 10b-5
Director |
Position |
Ordinary Shares Sold |
Share Sale Price |
|
% of total voting rights |
|
Chief Executive Officer |
804 3,624 1,994 1,790 2,920 2,228 2,984 |
|
4,038,191 |
2.82% |
For further information or enquiries please contact:
|
|
KCSA (US Investor Relations)
|
|
|
Tel: +44 20 7390 0230
|
finnCap Ltd
|
Tel: +44 20 7220 0500 |
|
Tel: +44 20 7710 7600
|
About
Tremor is headquartered in
For more information, visit www.tremorinternational.com and to learn more about the Company's recent rebranding, please visit www.nexxen.com.
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||||||||||
a) |
|
|
||||||||||||||||
2. |
Reason for the Notification |
|||||||||||||||||
a) |
Position/status |
Chief Executive Officer |
||||||||||||||||
b) |
Initial notification/Amendment |
Initial |
||||||||||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||
a) |
|
|
||||||||||||||||
b) |
LEI |
213800ZNSR7AIJZ2J557 |
||||||||||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||
a) |
Description of the Financial instrument, type of instrument |
Restricted Stock Units over Ordinary Shares of |
||||||||||||||||
Identification code |
IL0011320343 |
|||||||||||||||||
b) |
Nature of the transaction |
Sale of Ordinary Shares |
||||||||||||||||
c) |
Price(s) and volume(s) |
|
||||||||||||||||
d) |
Aggregated information: · Aggregated volume · Price |
|
||||||||||||||||
e) |
Date of the transaction |
|
||||||||||||||||
f) |
Place of the transaction |
NASDAQ Global Market |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the